Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Baruch Velan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Cell Line

Living Beings

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
81
Shafferman, Avigdor
43
Kronman, Chanoch
32
Ordentlich, Arie
26
Barak, Dov
24
Ariel, Naomi
15
Cohen, Sara
10
Segall, Yoffi
9
Mamroud, Emanuelle
9
Kaplan, Dana
8
Flashner, Yehuda
7
Chitlaru, Theodor
7
Lustig, Shlomo
6
Elhanany, Eytan
6
Ber, Raphael
5
Bino, Tamar

Sign-in to see all Coauthors

Publications

TOP 3
Lustig Shlomo; Maik-Rachline Galia; Paran Nir; Melamed Sharon; Israely Tomer; Erez Noam; Orr Nadav; Reuveny Shaul; Ordentlich Arie; Laub Orgad; Shafferman Avigdor; Velan Baruch
Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
Paran Nir; Suezer Yasemin; Lustig Shlomo; Israely Tomer; Schwantes Astrid; Melamed Sharon; Katz Lior; Preuss Thomas; Hanschmann Kay-Martin; Kalinke Ulrich; Erez Noam; Levin Reuven; Velan Baruch; Löwer Johannes; Shafferman Avigdor; Sutter Gerd
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Bar-Haim Erez; Gat Orit; Markel Gal; Cohen Hila; Shafferman Avigdor; Velan Baruch
Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Baruch Velan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lustig Shlomo; Maik-Rachline Galia; Paran Nir; Melamed Sharon; Israely Tomer; Erez Noam; Orr Nadav; Reuveny Shaul; Ordentlich Arie; Laub Orgad; Shafferman Avigdor; Velan Baruch
Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
Vaccine 2009;27(11):1691-9.
2009: Paran Nir; Suezer Yasemin; Lustig Shlomo; Israely Tomer; Schwantes Astrid; Melamed Sharon; Katz Lior; Preuss Thomas; Hanschmann Kay-Martin; Kalinke Ulrich; Erez Noam; Levin Reuven; Velan Baruch; Löwer Johannes; Shafferman Avigdor; Sutter Gerd
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
The Journal of infectious diseases 2009;199(1):39-48.
2008: Bar-Haim Erez; Gat Orit; Markel Gal; Cohen Hila; Shafferman Avigdor; Velan Baruch
Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection.
PLoS pathogens 2008;4(11):e1000211.
2008: Shafferman Avigdor; Barak Dov; Stein Dana; Kronman Chanoch; Velan Baruch; Greig Nigel H; Ordentlich Arie
Flexibility versus "rigidity" of the functional architecture of AChE active center.
Chemico-biological interactions 2008;175(1-3):166-72.
2008: Zauberman Ayelet; Cohen Sara; Levy Yinon; Halperin Gideon; Lazar Shirley; Velan Baruch; Shafferman Avigdor; Flashner Yehuda; Mamroud Emanuelle
Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Vaccine 2008;26(13):1616-25.
2007: Cohen Ofer; Kronman Chanoch; Lazar Arie; Velan Baruch; Shafferman Avigdor
Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants.
The Journal of biological chemistry 2007;282(49):35491-501.
2007: Zauberman Ayelet; Velan Baruch; Mamroud Emanuelle; Flashner Yehuda; Shafferman Avigdor; Cohen Sara
Disparity between Yersinia pestis and Yersinia enterocolitica O:8 in YopJ/YopP-dependent functions.
Advances in experimental medicine and biology 2007;603():312-20.
2006: Velan Baruch; Bar-Haim Erez; Zauberman Ayelet; Mamroud Emanuelle; Shafferman Avigdor; Cohen Sara
Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration.
Infection and immunity 2006;74(11):6365-76.
2006: Zauberman Ayelet; Cohen Sara; Mamroud Emanuelle; Flashner Yehuda; Tidhar Avital; Ber Raphael; Elhanany Eytan; Shafferman Avigdor; Velan Baruch
Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis.
Infection and immunity 2006;74(6):3239-50.
2005: Barak Dov; Ordentlich Arie; Kaplan Dana; Kronman Chanoch; Velan Baruch; Shafferman Avigdor
Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.
Chemico-biological interactions 2005;157-158():219-26.
2005: Kronman Chanoch; Cohen Ofer; Velan Baruch; Shafferman Avigdor
Host-regulated disposition of mammalian AChEs.
Chemico-biological interactions 2005;157-158():51-5.
2005: Ordentlich Arie; Barak Dov; Sod-Moriah Gali; Kaplan Dana; Mizrahi Dana; Segall Yoffi; Kronman Chanoch; Karton Yishai; Lazar Arie; Marcus Dino; Velan Baruch; Shafferman Avigdor
The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.
Chemico-biological interactions 2005;157-158():191-8.
2005: Shafferman Avigdor; Barak Dov; Kaplan Dana; Ordentlich Arie; Kronman Chanoch; Velan Baruch
Functional requirements for the optimal catalytic configuration of the AChE active center.
Chemico-biological interactions 2005;157-158():123-31.
2005: Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
Vaccine 2005;23(48-49):5688-97.
2005: Aloni-Grinstein R; Gat O; Altboum Z; Velan B; Cohen S; Shafferman A
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
Infection and immunity 2005;73(7):4043-53.
2004: Ordentlich Arie; Barak Dov; Sod-Moriah Gali; Kaplan Dana; Mizrahi Dana; Segall Yoffi; Kronman Chanoch; Karton Yishai; Lazar Arie; Marcus Dino; Velan Baruch; Shafferman Avigdor
Stereoselectivity toward VX is determined by interactions with residues of the acyl pocket as well as of the peripheral anionic site of AChE.
Biochemistry 2004;43(35):11255-65.
2004: Marcus Hadar; Danieli Rachel; Epstein Eyal; Velan Baruch; Shafferman Avigdor; Reuveny Shaul
Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
Infection and immunity 2004;72(6):3471-7.
2004: Kaplan Dana; Barak Dov; Ordentlich Arie; Kronman Chanoch; Velan Baruch; Shafferman Avigdor
Is aromaticity essential for trapping the catalytic histidine 447 in human acetylcholinesterase?
Biochemistry 2004;43(11):3129-36.
2004: Chitlaru Theodor; Ariel Naomi; Zvi Anat; Lion Menahem; Velan Baruch; Shafferman Avigdor; Elhanany Eytan
Identification of chromosomally encoded membranal polypeptides of Bacillus anthracis by a proteomic analysis: prevalence of proteins containing S-layer homology domains.
Proteomics 2004;4(3):677-91.
2004: Flashner Yehuda; Mamroud Emanuelle; Tidhar Avital; Ber Raphael; Aftalion Moshe; Gur David; Lazar Shirley; Zvi Anat; Bino Tamar; Ariel Naomi; Velan Baruch; Shafferman Avigdor; Cohen Sara
Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates.
Infection and immunity 2004;72(2):908-15.
2004: Cohen Ofer; Kronman Chanoch; Velan Baruch; Shafferman Avigdor
Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).
The Biochemical journal 2004;378(Pt 1):117-28.
2003: Ariel N; Zvi A; Makarova K S; Chitlaru T; Elhanany E; Velan B; Cohen S; Friedlander A M; Shafferman A
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.
Infection and immunity 2003;71(8):4563-79.
2003: Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
Infection and immunity 2003;71(2):801-13.
2003: Grosfeld Haim; Cohen Sara; Bino Tamar; Flashner Yehuda; Ber Raphael; Mamroud Emanuelle; Kronman Chanoch; Shafferman Avigdor; Velan Baruch
Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
Infection and immunity 2003;71(1):374-83.
2003: Mamroud Emanuelle; Flashner Yehuda; Tidhar Avital; Ber Raphael; Gur David; Aftalion Moshe; Lazar Shirley; Velan Baruch; Shafferman Avigdor; Cohen Sara
Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.
Advances in experimental medicine and biology 2003;529():425-30.
2003: Grosfeld Haim; Bino Tamar; Flashner Yehuda; Ber Raphael; Mamroud Emanuelle; Lustig Shlomo; Velan Baruch; Shafferman Avigdor; Cohen Sara
Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.
Advances in experimental medicine and biology 2003;529():423-4.
2003: Flashner Yehuda; Mamroud Emanuelle; Tidhar Avital; Ber Raphael; Aftalion Moshe; Gur David; Zvi Anat; Ariel Naomi; Velan Baruch; Shafferman Avigdor; Cohen Sara
Identification of genes involved in Yersinia pestis virulence by signature-tagged mutagenesis.
Advances in experimental medicine and biology 2003;529():31-3.
2002: Ariel N; Zvi A; Grosfeld H; Gat O; Inbar Y; Velan B; Cohen S; Shafferman A
Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening.
Infection and immunity 2002;70(12):6817-27.
2002: Barak Dov; Kaplan Dana; Ordentlich Arie; Ariel Naomi; Velan Baruch; Shafferman Avigdor
The aromatic "trapping" of the catalytic histidine is essential for efficient catalysis in acetylcholinesterase.
Biochemistry 2002;41(26):8245-52.
2002: Chitlaru Theodor; Kronman Chanoch; Velan Baruch; Shafferman Avigdor
Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.
The Biochemical journal 2002;363(Pt 3):619-31.
2001: Cohen O; Kronman C; Chitlaru T; Ordentlich A; Velan B; Shafferman A
Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.
The Biochemical journal 2001;357(Pt 3):795-802.
2001: Elhanany E; Ordentlich A; Dgany O; Kaplan D; Segall Y; Barak R; Velan B; Shafferman A
Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts.
Chemical research in toxicology 2001;14(7):912-8.
2001: Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Biochemistry 2001;40(25):7433-45.
2001: Velan B
Immunoscreening after hybrid selection and translation.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 6():Unit6.8.
2001: Reuveny S; White M D; Adar Y Y; Kafri Y; Altboum Z; Gozes Y; Kobiler D; Shafferman A; Velan B
Search for correlates of protective immunity conferred by anthrax vaccine.
Infection and immunity 2001;69(5):2888-93.
2001: Chitlaru T; Kronman C; Velan B; Shafferman A
Effect of human acetylcholinesterase subunit assembly on its circulatory residence.
The Biochemical journal 2001;354(Pt 3):613-25.
2000: Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman J L
Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
Acta crystallographica. Section D, Biological crystallography 2000;56(Pt 11):1385-94.
2000: Kronman C; Chitlaru T; Elhanany E; Velan B; Shafferman A
Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase.
The Journal of biological chemistry 2000;275(38):29488-502.
2000: Cohen S; Mendelson I; Altboum Z; Kobiler D; Elhanany E; Bino T; Leitner M; Inbar I; Rosenberg H; Gozes Y; Barak R; Fisher M; Kronman C; Velan B; Shafferman A
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.
Infection and immunity 2000;68(8):4549-58.
2000: Barak D; Ordentlich A; Kaplan D; Barak R; Mizrahi D; Kronman C; Segall Y; Velan B; Shafferman A
Evidence for P-N bond scission in phosphoroamidate nerve agent adducts of human acetylcholinesterase.
Biochemistry 2000;39(5):1156-61.
1999: Malany S; Baker N; Verweyst M; Medhekar R; Quinn D M; Velan B; Kronman C; Shafferman A
Theoretical and experimental investigations of electrostatic effects on acetylcholinesterase catalysis and inhibition.
Chemico-biological interactions 1999;119-120():99-110.
1999: Ordentlich A; Barak D; Kronman C; Benschop H P; De Jong L P; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Biochemistry 1999;38(10):3055-66.
1998: Chitlaru T; Kronman C; Zeevi M; Kam M; Harel A; Ordentlich A; Velan B; Shafferman A
Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.
The Biochemical journal 1998;336 ( Pt 3)():647-58.
1998: Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
The Biochemical journal 1998;335 ( Pt 1)():95-102.
1998: Mendelson I; Kronman C; Ariel N; Shafferman A; Velan B
Bovine acetylcholinesterase: cloning, expression and characterization.
The Biochemical journal 1998;334 ( Pt 1)():251-9.
1998: Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
Functional characteristics of the oxyanion hole in human acetylcholinesterase.
The Journal of biological chemistry 1998;273(31):19509-17.
1997: Shafferman A; Ordentlich A; Barak D; Stein D; Ariel N; Velan B
Aging of somanyl-acetylcholinesterase adducts: facts and models.
The Biochemical journal 1997;324 ( Pt 3)():996-8.
1997: Barak R; Ordentlich A; Barak D; Fischer M; Benschop H P; De Jong L P; Segall Y; Velan B; Shafferman A
Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry.
FEBS letters 1997;407(3):347-52.
1996: Velan B; Barak D; Ariel N; Leitner M; Bino T; Ordentlich A; Shafferman A
Structural modifications of the omega loop in human acetylcholinesterase.
FEBS letters 1996;395(1):22-8.
1996: Shafferman A; Ordentlich A; Barak D; Stein D; Ariel N; Velan B
Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre.
The Biochemical journal 1996;318 ( Pt 3)():833-40.
1996: Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Molecular pharmacology 1996;50(3):639-49.
1996: Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors.
The Journal of biological chemistry 1996;271(20):11953-62.
1996: Shafferman A; Lustig S; Inbar Y; Halevy M; Schneider P; Bino T; Leitner M; Grosfeld H; Velan B; Schödel F; Cohen S
Alphavirus hybrid virion vaccines.
Advances in experimental medicine and biology 1996;397():41-7.
1995: Barak D; Ordentlich A; Bromberg A; Kronman C; Marcus D; Lazar A; Ariel N; Velan B; Shafferman A
Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite.
Biochemistry 1995;34(47):15444-52.
1995: Kronman C; Velan B; Marcus D; Ordentlich A; Reuveny S; Shafferman A
Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.
The Biochemical journal 1995;311 ( Pt 3)():959-67.
1995: Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase.
The Journal of biological chemistry 1995;270(5):2082-91.
1994: Kronman C; Ordentlich A; Barak D; Velan B; Shafferman A
The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis.
The Journal of biological chemistry 1994;269(45):27819-22.
1994: Velan B; Kronman C; Flashner Y; Shafferman A
Reversal of signal-mediated cellular retention by subunit assembly of human acetylcholinesterase.
The Journal of biological chemistry 1994;269(36):22719-25.
1994: Shafferman A; Ordentlich A; Barak D; Kronman C; Ber R; Bino T; Ariel N; Osman R; Velan B
Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase.
The EMBO journal 1994;13(15):3448-55.
1994: Seidman S; Aziz-Aloya R B; Timberg R; Loewenstein Y; Velan B; Shafferman A; Liao J; Norgaard-Pedersen B; Brodbeck U; Soreq H
Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos.
Journal of neurochemistry 1994;62(5):1670-81.
1994: Ashani Y; Grunwald J; Kronman C; Velan B; Shafferman A
Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
Molecular pharmacology 1994;45(3):555-60.
1994: Barak D; Kronman C; Ordentlich A; Ariel N; Bromberg A; Marcus D; Lazar A; Velan B; Shafferman A
Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core.
The Journal of biological chemistry 1994;269(9):6296-305.
1993: Velan B; Kronman C; Ordentlich A; Flashner Y; Leitner M; Cohen S; Shafferman A
N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis.
The Biochemical journal 1993;296 ( Pt 3)():649-56.
1993: Ordentlich A; Kronman C; Barak D; Stein D; Ariel N; Marcus D; Velan B; Shafferman A
Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center.
FEBS letters 1993;334(2):215-20.
1993: Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
The Journal of biological chemistry 1993;268(23):17083-95.
1993: Kerem A; Kronman C; Bar-Nun S; Shafferman A; Velan B
Interrelations between assembly and secretion of recombinant human acetylcholinesterase.
The Journal of biological chemistry 1993;268(1):180-4.
1993: Lazar A; Reuveny S; Kronman C; Velan B; Shafferman A
Evaluation of anchorage-dependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells.
Cytotechnology 1993;13(2):115-23.
1992: Kronman C; Velan B; Gozes Y; Leitner M; Flashner Y; Lazar A; Marcus D; Sery T; Papier Y; Grosfeld H
Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit.
Gene 1992;121(2):295-304.
1992: Shafferman A; Velan B; Ordentlich A; Kronman C; Grosfeld H; Leitner M; Flashner Y; Cohen S; Barak D; Ariel N
Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center.
The EMBO journal 1992;11(10):3561-8.
1992: Grosfeld H; Lustig S; Gozes Y; Velan B; Cohen S; Leitner M; Lachmi B; Katz D; Olshevski U; Shafferman A
Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.
Journal of virology 1992;66(2):1084-90.
1991: Velan B; Grosfeld H; Kronman C; Leitner M; Gozes Y; Lazar A; Flashner Y; Marcus D; Cohen S; Shafferman A
The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant.
The Journal of biological chemistry 1991;266(35):23977-84.
1991: Grosfeld H; Velan B; Leitner M; Lustig S; Lachi B E; Cohen S; Shafferman A
Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus.
Vaccine 1991;9(6):451-6.
1991: Velan B; Kronman C; Grosfeld H; Leitner M; Gozes Y; Flashner Y; Sery T; Cohen S; Ben-Aziz R; Seidman S
Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme.
Cellular and molecular neurobiology 1991;11(1):143-56.
1990: Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B
Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
Archives of virology 1990;113(1-2):99-106.
1989: Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi B E; Shafferman A
Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
Journal of virology 1989;63(8):3416-22.
1989: Schwers A; Severin J E; Bublot M; Maenhoudt M; Pastoret P P; Vanden Broecke C; Zilimwabagabo P; Velan B; Cohen S; Shafferman A
Protection of cattle from infection with vaccinia virus by bovine interferon alpha C.
The Veterinary record 1989;125(1):15-6.
1989: Kobiler D; Grosfeld H; Leitner M; Monzain R; Frist C; Seri T; Cohen S; Velan B; Shafferman A; Gozes Y
Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurification.
Journal of interferon research 1989;9(2):189-93.
1987: Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
The Journal of biological chemistry 1987;262(13):6227-37.
1986: Cohen S; Velan B; Bino T; Rosenberg H; Shafferman A
Induction and characterization of bovine leukocyte interferon.
Methods in enzymology 1986;119():136-44.
1986: Velan B; Cohen S; Grosfeld H; Shafferman A
Isolation of bovine IFN-alpha genes and their expression in bacteria.
Methods in enzymology 1986;119():464-74.
1985: Velan B; Cohen S; Grosfeld H; Leitner M; Shafferman A
Bovine interferon alpha genes. Structure and expression.
The Journal of biological chemistry 1985;260(9):5498-504.
1985: Grosfeld H; Cohen S; Velan B; Shafferman A
Genetic engineering of human interferons from lymphoblastoid cells: III. Purification, physicochemical and biological properties of bacterial IFN-alpha J1.
Advances in biotechnological processes 1985;4():59-78.
1985: Shafferman A; Cohen S; Grosfeld H; Leitner M; Velan B
Genetic engineering of human interferons from lymphoblastoid cells: II. Construction of trp expression plasmids and their use for efficient expression of IFN-alpha J1.
Advances in biotechnological processes 1985;4():25-57.
1985: Velan B; Cohen S; Grosfeld H; Shalita Z; Shafferman A
Cloning of a bovine interferon-alpha gene subfamily and comparisons between genetically engineered and leukocyte bovine interferons.
Developments in biological standardization 1985;60():355-69.
1985: Cohen S; Velan B; Shafferman A
Genetic engineering of human interferons from lymphoblastoid cells: I. Cloning of interferon species expressed in Sendai-induced Namalva cells.
Advances in biotechnological processes 1985;4():1-23.
1985: Cohen S; Velan B; Grosfeld H; Shalita Z; Leitner M; Shafferman A
Cloning, expression and biological activity of a new variant of human interferon alpha identified in virus induced lymphoblastoid cells.
Developments in biological standardization 1985;60():111-22.
1984: Grosfeld H; Cohen S; Velan B; Shalita Z; Shafferman A
Mutations not altering the symmetrical sequences in the trp operator yield a constitutive phenotype.
Molecular & general genetics : MGG 1984;195(1-2):358-60.

Sign-in to see more